StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UBS Reiterates Buy Rating on Marvell (MRVL), Says Investors Too Focused on High Profile Custom XPU Programs
March 12, 2026 10:51 AM
UBS analyst Timothy Arcuri reiterated a Buy rating and $120.00 price target on Marvell (NASDAQ: MRVL).The analyst commented, "We emerge ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
